SAK CORP's Net Worth
$1.21 Billion
Who is SAK CORP?
SAK CORP has an estimated net worth of $1.21 Billion. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., IDENIX PHARMACEUTICALS INC, BreitBurn Energy Partners L.P., KERYX BIOPHARMACEUTICALS INC, FACET BIOTECH CORP, and RHI Entertainment, Inc..
SEC CIK
SAK CORP's CIK is 0001061088
Past Insider Trading and Trends
2008 was SAK CORP's most active year for acquiring shares with 1 total transactions. SAK CORP's most active month to acquire stocks was the month of December. 2009 was SAK CORP's most active year for disposing of shares, totalling 5 transactions. SAK CORP's most active month to dispose stocks was the month of August. 2014 saw SAK CORP paying a total of $106,731,566.50 for 16,420,241 shares, this is the most they've acquired in one year. In 2014 SAK CORP cashed out on 53,331,109 shares for a total of $1,306,612,170.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Orexigen Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDENIX PHARMACEUTICALS INC No price found
InvestorSAK CORP owns 53,331,109 units of Common Stock. In the year 2013 SAK CORP acquired a total of 16,420,241 shares in IDENIX PHARMACEUTICALS INC at a cost of $106,731,566.50, SAK also disposed a total of 53,331,109 shares of IDENIX PHARMACEUTICALS INC equalling to $1,306,612,170.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -53.33M |
$24.50 | -$1,306,612,170.50 |
0
|
Aug 5
| |||
Form 4
| +44.49% | 16.42M |
$6.50 | $106,731,566.50 | 53.33M |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BreitBurn Energy Partners L.P. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FACET BIOTECH CORP No price found
InvestorSAK CORP owns 3,506,875 units of Common Stock, $0.01 par value per share. In the year 2009 SAK CORP filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.83% | -867.53K |
$15.43 | -$13,382,286.09 | 3.51M |
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||